BUSINESSSEMAFOR
Novo sues Lilly amid escalating weight-loss rivalry
Novo Nordisk sued Eli Lilly for misleading advertising in the US weight-loss drug market, alleging outdated weight-loss comparisons. Novo also previously sued Hims & Hers over a copycat version of Wegovy. The dispute highlights differences in global advertising regulations, as most countries prohibit ads for prescription-only medications.
Mentioned
Related Signal
Adjacent reporting
- Novo Nordisk is suing Eli Lilly over ads it says mislead consumers on weight loss drug efficacy
- Novo Nordisk sues competitor Eli Lilly over GLP-1 advertising
- Novo Nordisk sues Eli Lilly, alleging the company's GLP-1 ads are 'deliberately false'
- Ozempic maker Novo Nordisk sues US rival over ‘materially misleading’ ads
- Novo Nordisk sues Eli Lilly, accusing it of false advertising
- Novo Nordisk sues Eli Lilly over ads comparing GLP-1 medications